Correction for Li et al., Gα_i1 and Gα_i3 regulate macrophage polarization by forming a complex containing CD14 and Gab1

IMMUNOLOGY AND INFLAMMATION Correction for “Gα_i1 and Gα_i3 regulate macrophage polarization by forming a complex containing CD14 and Gab1,” by Xianjing Li, Duowei Wang, Zhen Chen, Ermei Lu, Zhuo Wang, Jingjing Duan, Wei Tian, Yun Wang, Linjun You, Yulian Zou, Yan Cheng, Qingyi Zhu, Xiaojian Wan, Tao Xi, Lutz Birnbaumer, and Yong Yang, which was first published March 30, 2015; 10.1073/pnas.1503779112 (Proc Natl Acad Sci USA 112:4731–4736).

The authors wish to note that Meisheng Jiang, Yuyuan Han, Cong Cao, and Wen-Ming Chu should be added to the author list as the 15th, 16th, 17th, and 19th authors, respectively. Meisheng Jiang, Yuyuan Han, and Cong Cao should each be credited with performing research. Wen-Ming Chu should be credited with designing the research. Wen-Ming Chu and Yong Yang should be credited with conceiving, developing, and planning the study. Wen-Ming Chu should also be listed as a cocorresponding author, in addition to Lutz Birnbaumer and Yong Yang.

The authors also note that the following statement should be added to the Acknowledgments: “We are very grateful to Dr. Gen-Sheng Feng at UC San Diego for providing Gab1 WT and Gab1 KO MEFs. This work was also supported in part by Department of Defense Grant PR054819 (to W.-M.C.), NIH Grant AI054128 (to W.-M.C.), and the Leukemia and Lymphoma Society (W.-M.C.), and by NIH Grant DK069771 (to M.J.).

The corrected author line, affiliation line, and author contributions appear below. The online version of the article has been corrected.

Xianjing Li^a, Duowei Wang^a, Zhen Chen^a, Ermei Lu^a, Zhuo Wang^a, Jingjing Duan^a, Wei Tian^a, Yun Wang^a, Linjun You^a, Yulian Zou^a, Yan Cheng^a, Qingyi Zhu^b, Xiaojian Wan^c, Tao Xi^a, Meisheng Jiang^d, Yuyuan Han^e, Cong Cao^e, Lutz Birnbaumer^f, Wen-Ming Chu^e,g, and Yong Yang^a

^aState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing 211198, China; ^bDepartment of Urology, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing 210029, China; ^cDepartment of Anesthesiology and Intensive Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China; ^dDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095; ^eDepartment of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912; ^fLaboratory of Neurobiology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709; and ^gUniversity of Hawaii Cancer Center, Honolulu, HI 96813

Author contributions: X.L., Z.C., Q.Z., L.B., W.-M.C., and Y.Y. designed research; X.L., E.L., Z.W., J.D., W.T., Y.W., L.Y., Y.Z., Y.C., X.W., M.J., Y.H., and C.C. performed research; L.B. and Y.Y. contributed new reagents/analytic tools; X.L., D.W., Z.C., E.L., T.X., L.B., and Y.Y. analyzed data; X.L., D.W., L.B., and Y.Y. wrote the paper; and W.-M.C. and Y.Y. conceived, developed, and planned the study.